Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial
Stephen A. Falk, Max Whibley, Andrew G. Renehan, Lindy Berkman et al.
Citations
13 citations
Journal
The Lancet Oncology
Topics
Colorectal and Anal Carcinomas
Field-Weighted Citation Impact (FWCI)
26.08
article
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial
Stephen A. Falk, Max Whibley, Andrew G. Renehan, Lindy Berkman, Natalie L. Abbott, Shaharyar M. Khan, Richard Adams, Henry M. Wood, Joanne Copeland, M. Hawkins, Susan D. Richman, Alexandra Gilbert, David Sebag‐Montefiore, Rob Glynne‐Jones, Vicky Goh, Sarah Brown, Duncan C. Gilbert, Daniel Bottomley, Alexandra Stewart, Sheela Rao, Sharon Ruddock, Joanne Webster, Alexandra Smith, Nuno Casanova, Mark Harrison, R. Muirhead
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet OncologyVol. 26(6)
Institutions
University of Leeds (GB), Royal Marsden NHS Foundation Trust (GB), Institute of Cancer Research (GB), King's College London (GB), Royal Sussex County Hospital (GB), Mount Vernon Hospital (GB), Churchill Hospital (GB), St James's University Hospital (GB), At Bristol (GB), Royal Marsden Hospital (GB), Cancer Research UK Clinical Trials Unit (GB), University Hospitals Sussex NHS Foundation Trust (GB), University College London (GB), Cardiff University (GB)